−0.8478USD
−11.28 MUSD
11.09 M
About NeuroSense Therapeutics Ltd.
Sector
CEO
Alon Ben-Noon
Headquarters
Herzliya
Website
Employees (FY)
18
Founded
2017
ISIN
IL0011811630
FIGI
BBG013YVW4Q4
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company. The firm is focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. It is involved in the 2b/3 clinical trial using its product candidate, PrimeC in patients with ALS and also commencing research into other possible indications for the drug, including Alzheimer’s and Parkinson’s diseases. The company was founded by Alon Ben-Noon on February 13, 2017 and is headquartered in Herzliya, Israel.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
